Schonfeld Strategic Advisors »

Trevi Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 76k 18.65
2020-03-31 $194k 59k 3.29
2019-12-31 $631k 168k 3.75
2019-09-30 $760k 169k 4.50
2019-06-30 $1.8M 234k 7.50

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Micron Technology (MU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Msci Brazil Etf (EWZ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vale S A Sponsored Ads (VALE)
Petroleo Brasileiro S A Sponsored Adr (PBR)

View all positions for Schonfeld Strategic Advisors

Top funds holding Trevi Therapeutics

NEA Management Company
FMR
BlackRock
Frazier Life Sciences Management
Wellington Management Company
Vanguard Capital Management
Vivo Capital
Woodline Partners
Vestal Point Capital
MPM Oncology Impact Management
Frontier Capital Management
Geode Capital Management
Marshall Wace
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics